What the business is, and whether it's a good one at a fair price.
Operates a chain of medical diagnostic centres offering pathology testing, X-ray, Ultrasound, ECG, TMT and ECHO services to individual patients and institutional clients. The most recent operational update is the opening of a new strategic centre at Vardhman Star City Mall in Dwarka, New Delhi, positioned to tap the government-employee population in the Dwarka and Palam belt, with management indicating expected revenue of approximately Rs. 1 crore per annum from that facility. FY26 revenue from operations stood at Rs. 418.58 lacs, down about 6% from Rs. 445.38 lacs in FY25. The cost structure is dominated by materials (40.3% of revenue) and other operating expenses (39.1%), with employee costs at 18.9% and capex at 7.9% of revenue. The audited results for FY26 flagged NPA status with lenders, defaults on loan repayments, and unpaid PF/ESIC/TDS statutory dues since July 2024, with a pre-exceptional loss of Rs. 51.31 lacs offset by a one-time OTS gain of Rs. 61.08 lacs to reach a small reported profit.
Measured from the filed financials, judged against its Healthcare Service Provider peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from DR LALCHANDANI LABS LIMITED's filed financials and exchange disclosures
DR LALCHANDANI LABS LIMITED is a Healthcare Services company listed on BSE.
Effectively yes. It holds ₹4 Cr more cash than debt.
On trailing P/E, DR LALCHANDANI LABS LIMITED ranks 5 of 29 in Healthcare Service Provider — cheaper than 86% of them, against an industry median of 23.2×. This is a position, not a valuation judgement.
On a typical session DR LALCHANDANI LABS LIMITED moves 3.88% — that is the median absolute close-to-close move across its last 146 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by DR LALCHANDANI LABS LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
